Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-08

Clinical Trial Update: The Savella Pregnancy Registry

View source ↗

Summary

The Savella (milnacipran) pregnancy registry study for fibromyalgia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Syneos Health | Conditions: Fibromyalgia | Status: TERMINATED